Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (23)
  • 2025 (70)
  • 2024 (84)
  • 2023 (102)
  • 2022 (93)
  • 2021 (67)
  • 2020 (17)
  • 2019 (10)
  • 2018 (4)

Subject

  • Drug Trafficking (4205)
  • Synthetic drugs (1139)
  • Guns/Weapons (1038)
  • OCDETF/Task Force (820)
  • Fake Pills (688)
  • Arrests/Convictions - Major (643)
  • Guilty Plea (557)
  • Seizures (Drugs/Property) (482)
  • Prescription Drugs (371)
  • Overdose (327)
  • Major Law Enforcement Operation (277)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (237)
  • Pharmaceuticals/Pharmacists/Physicians (228)
  • Gangs (202)
  • Outreach/Drug Prevention (188)
  • Fentanyl Awareness (166)
  • One Pill Can Kill (118)
  • HIDTA (105)
  • Press Conferences (68)
  • Narcoterrorism (55)
  • Prevention/Education - DEA websites GSAD, JTT etc (54)
  • Extraditions (52)
  • Public and Media Affairs - also see Congressional Affairs (51)
  • Fentanyl Free America (39)
  • Counterfeit Pills (38)
  • Asset Forfeiture (30)
  • Dark Web- Internet Trafficking (29)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Campaigns (13)
  • Other (12)
  • Critical Incident (9)
  • Intergovernmental Affairs (9)
  • Cartel (6)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Diversion Division (254)
  • Money Laundering (218)

Drug Name

  • Fentanyl (89)
  • Cocaine (77)
  • Methamphetamine (64)
  • Opioids (43)
  • Oxycodone (39)
  • Heroin (34)
  • Hydromorphone (16)
  • Marijuana (Cannabis) (16)
  • Synthetic Opioids (13)
  • Benzodiazepines (9)
  • Morphine (7)
  • Amphetamines (4)
  • Ecstasy/MDMA (3)
  • Methadone (3)
  • Steroids (3)
  • Ketamine (2)
  • Marijuana Concentrates (2)
  • K2/Spice (1)
  • Psilocybin (1)

Field Division

  • New England (69)
  • Washington, DC (51)
  • St. Louis (38)
  • Seattle (35)
  • New York (34)
  • Houston (33)
  • Chicago (29)
  • Miami (29)
  • Atlanta (23)
  • New Jersey (23)
  • Headquarters (16)
  • El Paso (14)
  • San Francisco (14)
  • Phoenix (10)
  • Dallas (9)
  • New Orleans (9)
  • San Diego (9)
  • Rocky Mountain (7)
  • Detroit (5)
  • Los Angeles (5)
  • Louisville (5)
  • Omaha (3)
Clear All Results
470 Results - Showing 151 to 160
PRESS RELEASE

Idaho Doctor Pays $96,000 to Settle Allegations That He Wrote Unlawful Prescriptions

POCATELLO – Dr. Gerald Knouf, a family medicine doctor formerly of Pocatello, Idaho, agreed to pay $96,000 to resolve allegations that he wrote unlawful prescriptions, prescribed dangerous combinations of drugs, and billed Medicare and Medicaid for services that were not performed, U.S. Attorney Josh Hurwit announced today. The settlement also...
PRESS RELEASE

41 Charged in Massive Poly-Drug Indictment Linked to Cartel

GALVESTON, Texas – A total of 23 people were taken into custody following the return of a 50-count indictment alleging cocaine, fentanyl, heroin and meth trafficking and related crimes in the Houston and Galveston areas, announced Drug Enforcement Administration (DEA) Special Agent in Charge, Daniel C. Comeaux, Houston Division and...
PRESS RELEASE

Owner Of New Jersey Company Admits to Evading U.S. Customs Duties and His Company Agrees to a $3.1 Million Settlement Agreement

NEWARK, N.J. – The owner of a New Jersey company today admitted mislabeling hazardous chemicals entering the United States and evading customs duties, DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today. George Volpe, 60, of Roseland, New Jersey, owner...
PRESS RELEASE

Chemical Importer to Pay $300,000 in Civil Penalties for Alleged Violations of the Controlled Substances Act

WACO, Texas – Shrieve Chemical Company, LLC, a Drug Enforcement Administration-registered importer and distributor of listed chemicals, has agreed to pay $300,000 in civil penalties to resolve allegations that it violated provisions of the Controlled Substances Act, 21 U.S.C. §§ 801 et seq. In December 2022, DEA diversion investigators conducted...
PRESS RELEASE

Owner of Oakland Money Services Business Sentenced to 18 Months in Prison for Laundering Drug Proceeds to Mexico

OAKLAND, Calif. – Felipe de Jesus Ornelas Mora, the owner of Rincon Musical, a money transmitting business in Oakland, was sentenced today to 18 months in federal prison following his conviction for conspiracy to commit money laundering, announced First Assistant United States Attorney Patrick D. Robbins; IRS Criminal Investigation (CI)...
PRESS RELEASE

Ringleader of Fentanyl Conspiracy Sentenced to Life, Co-Conspirators Sentenced to a Total of More than 100 Years

INDIANAPOLIS, Ind. – Michael Gannon, Assistant Special Agent in Charge of U.S. Drug Enforcement Administration-Indianapolis, and U.S. Attorney Zachary A. Myers for the Southern District of Indiana announced Keith J. Jones, a/k/a Keybo, 57, of Indianapolis, Indiana, and Kevin M. Backstrom, 58, of Los Angeles California have been sentenced to...
PRESS RELEASE

Nurse Practitioner Sentenced to 70 Months for Unlawful Drug Distribution

ALBANY, NEW YORK – Danielle Simonson, age 52, of Fort Ann, New York, was sentenced today to 70 months in prison for distributing controlled substances outside the course of professional practice and for no legitimate medical purpose. United States Attorney Carla B. Freedman; Special Agent in Charge Frank A. Tarentino...
PRESS RELEASE

DEA Issues Letter to E-Commerce Companies on the Sale of Pill Presses Used to Make Fentanyl Pills

WASHINGTON – The U.S. Drug Enforcement Administration today issued a letter to e-commerce companies regarding the sale of pill presses. As regulated entities under the Controlled Substances Act (CSA), e-commerce platforms are generally required to comply with CSA recordkeeping, identification, and reporting requirements on the distribution, importation, and exportation of...
PRESS RELEASE

Drug Coordinator Sentenced to 63 Months in Prison

TUCSON, Ariz. – Enrique Heriberto Nunez-Tiznado, 45, of Sasabe, Sonora, Mexico, was sentenced on February 22, 2024, by United States District Judge Scott H. Rash to 63 months in prison. Nunez-Tiznado pleaded guilty to Possession with Intent to Distribute Fentanyl, Heroin, Cocaine, and Methamphetamine, and Conspiracy to Launder Monetary Instruments...
PRESS RELEASE

Five Individuals Sentenced to Prison for Meth Trafficking and Money Laundering

GREEN BAY, Wis. – John McGarry, Assistant Special Agent in Charge of U.S. Drug Enforcement Administration-Milwaukee and U.S. Attorney Gregory J. Haanstad, for the Eastern District of Wisconsin, announced that on February 14, 2024, five individuals were sentenced by United States Senior District Court Judge William C. Griesbach for their...

Pagination

  • First page «
  • Previous
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Current page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Next
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster